With newly designed eBase® Controller for better handling and more mobility
The eFlow®rapid nebuliser system with new eBase Controller is suitable for the treatment of a wide range of diseases of the lower airways. It stands for efficient, safe and fast inhalation treatment, combined with even more advantages:
- Flexible use thanks to handy controller design, battery pack and light, small and silent device.
- Individuality due to setting options that allow to adjust the controller lights and sounds according to individual requirements
- Time-saving - immediate switch-off at the end of inhalation and short nebulisation times [1] thanks to eFlow® Technology
Aerosol characteristics of the eFlow®rapid nebuliser system
|
MMADa):
|
4,6 µm
|
|
Respirable Fractiona) < 5 µm:
|
55 %
|
|
Aerosol Output Rateb):
|
0,5 g/min
|
Aerosol data according to ISO 27427; nebulised medium: Salbutamol 2.5 ml. Measured values may vary depending on the medication used. Recommended fill volume: see package leaflet for the medication.
a) Measurement with Next Generation Pharmaceutical Impactor (NGI) at 23 °C and 50% relative humidity. Inspiratory flow: 15 l/min
b) Measurement with breathing simulator at 23 °C and 50 % relative humidity. 500 ml breathing volume, breathing frequency 15 cycles/minute, sinusoidal breathing pattern, inhalation/exhalation ratio 1:1 (with adults, may vary in children).
With newly designed eBase® Controller for better handling and more mobility
The eFlow®rapid nebuliser system with new eBase Controller is suitable for the treatment of a wide range of diseases of the ...
